Ingersoll Rand (IR) investor relations material

Executive summary

• Year-to-date organic orders up 2% with a book-to-bill ratio of 1.04x, supporting a positive growth outlook in a dynamic market.

• Revenues for Q3 2025 increased 5.1% year-over-year to $1,955 million, driven by acquisitions, higher pricing, and favorable currency impacts.

• Adjusted EBITDA for Q3 2025 was $545 million, up 2% year-over-year, with a margin of 27.9%.

• Net income for Q3 2025 was $245.8 million, up from $223.4 million in Q3 2024, with adjusted EPS at $0.86, up 2% year-over-year.

• Acquisition pipeline remains robust, with 14 transactions closed year-to-date and nine under letters of intent, focusing on high-return bolt-ons.

Financial highlights

• Q3 2025 orders up 8% year-over-year to $1,942 million, with a book-to-bill ratio of 0.99x for the quarter and 1.04x year-to-date.

• Q3 2025 revenue increased 5% year-over-year to $1,955 million; organic orders up 2%.

• Adjusted EBITDA for Q3 was $545 million, margin 27.9%; adjusted EPS was $0.86.

• Free cash flow for Q3 was $326 million, nearly flat year-over-year; liquidity stood at $3.8 billion.

• Net income for Q3 2025 was $245.8 million; diluted EPS was $0.61.

Outlook and guidance

• Full-year 2025 revenue growth expected at 4–6% year-over-year; organic revenue expected to be flat to down 2%.

• Adjusted EBITDA guidance midpoint revised to $2,075 million due to tariffs and backlog timing.

• Adjusted EPS guidance midpoint reduced to $3.28 from $3.40, reflecting tariff impacts and delayed price realization.

• Margin expansion expected to be muted in early 2026, with improvement anticipated in the second half as pricing actions take effect.

• Management expects continued macroeconomic uncertainty due to inflation, interest rates, and evolving trade policies.